Want to see HIT full AI Analyst Report?
HIT Stock Chart & Stats
$1.06
$0.00(0.00%)
At close: 4:00 PM EDT
$1.06
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.85 - $4.02
Previous Close$5.45
Volume11.84K
Average Volume (3M)86.29K
Market Cap
$65.86M
Enterprise Value$57.12
Total Cash (Recent Filing)$6.51M
Total Debt (Recent Filing)$102.94K
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding53,834,660
10 Day Avg. Volume58,983
30 Day Avg. Volume86,289
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)5.19
Price to Sales (P/S)2.66
P/FCF Ratio-1.58K
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.50Price Target Upside230.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.06
Revenue Forecast (FY)$46.83M
Bulls Say, Bears Say
Bulls Say
Very Low LeverageMinimal leverage gives Health In Tech financial flexibility to fund product development and distribution growth without substantial interest obligations. The stronger equity base also provides resilience if operating losses persist during the scaling phase.
Contracted Revenue And Pipeline VisibilityContracted revenue scheduled into late 2026 and 2027 provides multi-quarter visibility beyond reported GAAP revenue. The sizable pipeline and defined 15%–40% conversion expectation could support durable growth if execution and carrier onboarding remain effective.
Expanding Platform Network And AI ProductA growing broker, TPA and agency network can strengthen platform distribution and marketplace liquidity. HitRix’s AI-enabled quoting and comparison capabilities may broaden the addressable market and deepen the company’s role in self-funded insurance.
Bears Say
Profitability DeteriorationThe shift from prior profitability to losses indicates that current growth investments and operating costs are exceeding revenue contribution. Sustained negative margins could limit internally funded expansion and require stronger execution before the model demonstrates operating leverage.
Negative Cash Generation And Lower Cash BalanceOngoing operating and free-cash-flow deficits reduce the company’s ability to finance product, sales and carrier expansion internally. The lower cash balance increases dependence on improved collections, operating performance or external funding over the next several quarters.
Working-Capital And Margin PressureSlower collections tie up capital and can amplify liquidity pressure while the business scales. At the same time, lower expected gross margins from partner and distribution economics may constrain operating leverage, making revenue conversion quality important.
Health In Tech, Inc. Class A News
HIT FAQ
What was Health In Tech, Inc. Class A’s price range in the past 12 months?
Health In Tech, Inc. Class A lowest stock price was $0.85 and its highest was $4.02 in the past 12 months.
What is Health In Tech, Inc. Class A’s market cap?
Health In Tech, Inc. Class A’s market cap is $65.86M.
When is Health In Tech, Inc. Class A’s upcoming earnings report date?
Health In Tech, Inc. Class A’s upcoming earnings report date is Nov 16, 2026 which is in 90 days.
How were Health In Tech, Inc. Class A’s earnings last quarter?
Health In Tech, Inc. Class A released its earnings results on Aug 13, 2026. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of -$0.027 by -$0.013.
Is Health In Tech, Inc. Class A overvalued?
According to Wall Street analysts Health In Tech, Inc. Class A’s price is currently Undervalued.
Does Health In Tech, Inc. Class A pay dividends?
Health In Tech, Inc. Class A does not currently pay dividends.
What is Health In Tech, Inc. Class A’s EPS estimate?
Health In Tech, Inc. Class A’s EPS estimate is -0.02.
How many shares outstanding does Health In Tech, Inc. Class A have?
Health In Tech, Inc. Class A has 53,834,660 shares outstanding.
What happened to Health In Tech, Inc. Class A’s price movement after its last earnings report?
Health In Tech, Inc. Class A reported an EPS of -$0.04 in its last earnings report, missing expectations of -$0.027. Following the earnings report the stock price went down -5.189%.
Which hedge fund is a major shareholder of Health In Tech, Inc. Class A?
Currently, no hedge funds are holding shares in HIT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health In Tech, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (230.19% Upside)
$3.50 (230.19% Upside)
Blogger Sentiment
Bullish
HIT Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.36%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
39.00%
Trailing 12-Months
Company Description
Health In Tech, Inc. Class A
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.
HIT Company Deck
HIT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company highlighted meaningful forward-looking commercial traction — $32.3M contracted revenue, a $66.3M pipeline, $84M PPPV, nearly 20% YoY distribution growth, and major product/engineering milestones (HitRix launch, 3-year stabilization program). At the same time, near-term financials showed a Q2 GAAP revenue decline (-13.5%), negative adjusted EBITDA, widened AR days, and a reduced cash balance driven by carrier onboarding timing and increased investments. Management framed many negatives as timing or deliberate investments to scale the business, while reaffirming FY guidance. Given the sizable forward pipeline and product catalysts but clear short-term profitability and liquidity pressures, the call strikes a neutral tone between opportunity and execution/financial risk.View all HIT earnings summariesHIT Stock 12 Month Forecast
Average Price Target
$3.50
▲(230.19% Upside)
Technical Analysis
Ownership Overview
61.74% Insiders
1.32% Mutual Funds
5.61% Other Institutional Investors
30.16% Public Companies and
Individual Investors